Updates in Diagnosing and Treating CIDP

Accredited free neurology CME activity on updates in diagnosing and treating CIDP. Earn free CME credits with practical, evidence-based insights for Physicians and Neurologists.
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) represents a complex and heterogeneous immune-mediated neuropathy, where an evolving understanding of its immunopathogenesis has transformed approaches to diagnosis and long-term management. Once managed primarily through empiric immunotherapy, CIDP is now recognized as a condition requiring precise phenotypic characterization, biomarker-driven evaluation, and individualized treatment selection.